Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2017 August;152(4) > Giornale Italiano di Dermatologia e Venereologia 2017 August;152(4):327-32

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

ORIGINAL ARTICLE  


Giornale Italiano di Dermatologia e Venereologia 2017 August;152(4):327-32

DOI: 10.23736/S0392-0488.16.05287-X

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis

Vito DI LERNIA 1 , Iria NERI 2, Piergiacomo CALZAVARA PINTON 3, Sergio DI NUZZO 4, Luca STINGENI 5, Claudio GUARNERI 6, Anna BELLONI FORTINA 7, Domenico BONAMONTE 8, Stefano CAMBIAGHI 9, Claudia LASAGNI 10, Michele PANZONE 11, Monica CORAZZA 12, Annamaria OFFIDANI 13, Paolo GISONDI 14

1 Dermatology Unit, Department of Internal Medicine, Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia, Italy; 2 Dermatology Unit, Department of Specialist, Diagnostic and Experimental Medicine, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy; 3 Section of Dermatology, Department of Medicine, University of Brescia, Brescia, Italy; 4 Section of Dermatology, Department of Clinical and Experimental Medicine, Parma University Hospital, Parma, Italy; 5 Section of Clinical Dermatology, Allergology and Venereology, Department of Medicine, University of Perugia, Perugia, Italy; 6 Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, Messina, Italy; 7 Pediatric Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy; 8 Section of Dermatology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy; 9 Pediatric Dermatology Unit, Department of Pathophysiology and Transplantation, Maggiore Hospital, Polyclinic Hospital of Milan, Milan, Italy; 10 Dermatology Unit, Department of Head and Neck Surgery, University of Modena, Modena, Italy; 11 Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy; 12 Department of Medical Sciences, Section of Dermatology, University of Ferrara, Ferrara, Italy; 13 Dermatology Unit, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy; 14 Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy


PDF  


BACKGROUND: The majority of available systemic therapies have never been systematically investigated in moderate to severe childhood plaque psoriasis. For this reason, treatment preferences for moderate to severe psoriasis in childhood are still unknown. The aim of this study was to investigate the systemic treatment patterns of moderate to severe psoriasis in children and adolescents aged 18 or older in Italy. Additional secondary outcomes were duration of treatment and reasons for discontinuation.
METHODS: In order to define differences in treatment patterns, we performed a chart review of all consecutive patients treated with systemic drugs during an index period of 5 years. Consecutive sampling of all patients with psoriasis aged ≤18 years, who had been treated with at least one systemic drug over a 5-year period, was made.
RESULTS: The records of 58 consecutive patients, 27 males, 31 females. with moderate to severe psoriasis treated with at least one systemic therapy were reviewed. The median age (standard deviation) at the start of the first systemic treatment was 11.7±3.7 years. The most preferred first-line systemic treatment was cyclosporine, which was administered as first systemic treatment in 53.4% of patients, followed by acitretin in 22.4% of patients, etanercept and PUVA respectively in 8.6%, methotrexate in 6.8%. 48.2% of patients received a second systemic treatment due to inefficacy or side effects of the first-line therapy during the index period. Because of the small sample, and voluntary contribution, selection bias may have occurred.
CONCLUSIONS: A considerable variation in the management of the first-line systemic therapy in children with moderate to severe psoriasis was observed. Cyclosporine was most commonly preferred as a first-line treatment. The availability of new therapeutic agents could change the scenario of treatment patterns in childhood psoriasis.


KEY WORDS: Psoriasis - Pediatrics - Therapeutics - Cyclosporine - Methotrexate - Acitretin

top of page

Publication History

Issue published online: June 14, 2017
Article first published online: January 13, 2016
Manuscript accepted: December 29, 2015
Manuscript received: November 30, 2015

Cite this article as

Di Lernia V, Neri I, Calzavara Pinton P, Di Nuzzo S, Stingeni L, Guarneri C, et al. Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis. G Ital Dermatol Venereol 2017;152:327-32. DOI: 10.23736/S0392-0488.16.05287-X

Corresponding author e-mail

vito.dilernia@asmn.re.it